PEP pepper residential securities trust no. 39

Phase IIa trialClears 71% of skin cancer (basal cell cancinoma)...

  1. 1,154 Posts.
    Phase IIa trial

    Clears 71% of skin cancer (basal cell cancinoma) with 2 treatments.

    P = 0.02

    Very positive

    Moving now to larger clinical trial.

    G
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.